White House Health Care Policy adviser Ira Magaziner has made light of a New York Times story that the Clinton Administration may reduce his role in next year's health care reform campaign. He said the media is always interested in playing up conflicts, and that he is staying as a senior adviser. The reform issue will still be around in 1995 because the problem will only get worse, he said, but the administration will be better prepared to deal with the scare tactics and high-powered lobbying that led to its defeat this year.
The NYT reported that while White House chief of staff Leon panetta had been discussing ideas for a new policy-making process in which Mr Magaziner's responsibilities would be reduced, administration staff had said Mr Magaziner was lobbying to keep a major role, with Mrs Clinton's support. Several White House officials were quoted as saying he will still be part of the effort, but his role will be different. Others in the Administration, Congress and outside experts are lobbying for someone else to head the health policy operation, it added.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze